Eribulin: a new treatment option in metastatic breast cancer heavily pretreated?

被引:0
|
作者
Goncalves, Anthony
机构
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:455 / 455
页数:1
相关论文
共 50 条
  • [31] Safety and tolerability of eribulin mesylate in patients with pretreated metastatic breast cancer
    Goodin, Susan
    Barbour, Sally
    Song, James
    Berrak, Erhan
    Cox, David
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2015, 72 (24) : 2150 - 2156
  • [32] Metastatic colorectal Cancer (mCRC) New Treatment Option for pretreated Patients
    Arnold, Dirk
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 (09) : 577 - 577
  • [33] Eribulin mesylate in the treatment of metastatic breast cancer
    Jain, Sarika
    Cigler, Tessa
    BIOLOGICS-TARGETS & THERAPY, 2012, 6 : 21 - 29
  • [34] Thalidomide is inactive in heavily pretreated patients with metastatic breast cancer
    Morabito, A
    Carillio, G
    Longo, R
    Gasparini, G
    CANCER JOURNAL, 2005, 11 (03): : 248 - 251
  • [35] The Place for Eribulin in the Treatment of Metastatic Breast Cancer
    William J. Gradishar
    Current Oncology Reports, 2011, 13 : 11 - 16
  • [36] The Place for Eribulin in the Treatment of Metastatic Breast Cancer
    Gradishar, William J.
    CURRENT ONCOLOGY REPORTS, 2011, 13 (01) : 11 - 16
  • [37] The safety of eribulin for the treatment of metastatic breast cancer
    Manuel Perez-Garcia, Jose
    Cortes, Javier
    EXPERT OPINION ON DRUG SAFETY, 2019, 18 (05) : 347 - 355
  • [38] Combination of pembrolizumab and lenvatinib is a potential treatment option for heavily pretreated recurrent and metastatic head and neck cancer
    Chen, Tien-Hua
    Chang, Peter Mu-Hsin
    Yang, Muh-Hwa
    JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2021, 84 (04) : 361 - 367
  • [39] a new, effective treatment for women with heavily pretreated metastatic breast cancer (vol 3, pg 101, 2011)
    Menis, J.
    Twelves, C.
    BREAST CANCER-TARGETS AND THERAPY, 2012, 4 : 1 - 1
  • [40] Ixabepilone, a New Treatment Option for Metastatic Breast Cancer
    Toppmeyer, Deborah L.
    Goodin, Susan
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2010, 33 (05): : 516 - 521